Air Liquide, European leader in home healthcare, announces its support for IDF Europe (International Diabetes Federation European Region), the European headquarter of the International Diabetes Federation, in its advocacy and awareness-raising activities targeting people affected by this chronic illness, the society, and policymakers in Europe. The Group's support also aims to advance diabetes research.
Through this partnership, Air Liquide intends to contribute to informing as many people as possible about diabetes-related issues and support research in this area. Accordingly, the Group will support IDF Europe's communication and awareness-raising actions as well as the 2018 Young Researcher Prize. The purpose of the latter is to reward the work of a young researcher under 40 who is involved in research aimed at improving our knowledge of diabetes.
As part of its home healthcare business, Air Liquide takes care of numerous diabetic patients in Europe to help them improve their lives with the disease. The partnership with IDF Europe illustrates Air Liquide’s long-standing commitment to people suffering from chronic diseases and healthcare professionals, as well as its willingness to strengthen dialogue with the different stakeholders.
As a major public health issue, diabetes is a chronic illness that affects 425 million adults worldwide, i.e., 5.6% of the world's population. Today, 212 million1 people are still unaware that they have this disease. IDF Europe brings together 70 national organizations from 46 countries and gives a voice to people with diabetes, as well as the greater community and healthcare professionals, to encourage improvements in diabetes prevention, care, and treatment at the European level.
1IDF. Diabetes Atlas 8th edition 2017. Available at: http://diabetesatlas.org/resources/2017-atlas.html